SEC Form 4 · accession 0001415889-16-006286
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Troy Allen Rhonemus
Officer — CHIEF OPERATING OFFICER
Period of report
Jun 20, 2016
Accepted (ET)
Jun 21, 2016 · 8:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 20, 2016 | P | 5,000 | $3.80 | A | 10,000 | D | |
| Common StockF2,F3 | Jun 20, 2016 | P | 2,800 | $2.887 | A | 12,800 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,667 shares held by Toni A. Rhonemus IRA, the Reporting Person's spouse.
- F2Includes an aggregate of 4,467 shares held by Toni A. Rhonemus IRA, the Reporting Person's spouse.
- F3Such purchase was made by Toni A. Rhonemus IRA, and is thus beneficially owned by the Reporting Person.